Cell-free DNA as a biomarker for taxane treatment in advanced prostate cancer.

Semini Sumanasuriya,George Seed,Niven Mehra,Rossitza Christova,Lorna Pope,Jane Goodall,Penelope Flohr,Gemma Fowler,Diletta Bianchini,Pasquale Rescigno,Suzanne Carreira,Wei Yuan,Sandrine Macé,Mustapha Chadjaa,Johann S. de Bono

Cell-free DNA as a biomarker for taxane treatment in advanced prostate cancer.

2019

Semini Sumanasuriya
George Seed
Niven Mehra
Rossitza Christova
Lorna Pope
Jane Goodall
Penelope Flohr
Gemma Fowler
Diletta Bianchini
Pasquale Rescigno
Suzanne Carreira
Wei Yuan
Sandrine Macé
Mustapha Chadjaa
Johann S. de Bono

5070Background: Antitumor efficacy of chemotherapeutic drugs docetaxel and cabazitaxel against hormone-sensitive and castration-resistant prostate cancer (CRPC) is well recognized. The identificati...

Keywords:

Taxane
Prostate cancer
Biomarker (medicine)
Pathology
Cancer research
Cell-free fetal DNA
Medicine
Docetaxel
chemotherapeutic drugs
Cabazitaxel

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations